The World Bio Pharma 2019 Summit will bring together quality leaders to share in discussion, and give ideas for facing the future challenges of the industry. The World Bio Pharma 2019 Congress programme will bring experienced speakers, participants, and networking for the academics and industry to discover new opportunities and partnerships. The World Bio Pharma 2019 Meetings will also bring opportunities for focused research institutes, government agencies, start-ups and established companies to address the challenges in the biotechnology and pharma industry.

World Bio Pharma 2019 is comprised of Keynote/Plenary sessions, Academic and Industrial presentations, Poster presentations, Workshops, Symposiums, Networking sessions, Young scholar forums and one to one meetings.

The World Bio Pharam 2019 Conference will be covering recent topics of biotechnology and pharma such as Drug Discovery & Development, Drug Delivery, Biopharma Manufacturing, Biosimilars & Biologics, Bioavailability & Bioequivalence - BABE, Clinical Trails, Personalized Medicine, Intellectual Property, Regulatory Affairs, Vaccines, Advances in Antibiotics Discovery, Pharmacovigilance, Analytical and Bioanalytical Techniques, Biopharmaceutics Applications, Clinical Pharmacology, Pharmaceutical Toxicology, Analytical and Bioanalytical Techniques, Pharmaceutical Packaging and Marketing.

Hilaris Conferences believes that access to science is essential to sustainable development and this platform will surely discover new partnerships among the academics and industry, policymakers, innovators, investors and government agencies. Hilaris Conferences seeks the support of global attendees for the vision Together towards tomorrow. 

Hilaris Conferences is hosting international Conferences, Meetings, Events, Workshops, and Symposium in the areas of Life Sciences, Clinical and Medical Sciences, Healthcare, Agriculture & Food, Pharmaceuticals, Environmental Sciences, and Applied Engineering across the world. We welcome participants to join us to establish networking opportunities.

Hilaris Conferences is hosting World Bio Pharma 2019 in London, UK. This platform will provide networking opportunities and partnerships among the academic, industry and government representatives. The World Bio Pharma 2019 Conference attendees will share new insights and developments in the area of biotechnology, pharma, and allied areas. The participants will be from Research Institute, CRO & Analytical Labs, CMOs, Clinics, Biotechnology and Pharma Industries. 

Scope/ Target Audience for World Bio Pharma 2019 London, UK

Participants from Industry:
The world biopharma development and manufacturing industry are growing fastly. The Bio Pharma 2019 Meetings warmly welcomes Industry Researchers, Chief Executive Officers, Directors, Chief Scientific Officers, Chief Medical Officers, Head of Regulatory Affairs, Chief Operating Officer, Head of Legal & Intellectual Property, Research Heads, Consultants, Business Development & Sales Teams, Policymakers, Investors, Government Officials and other participants from:

  • Pharma Research Companies
  • Pharma Formulation Companies
  • Biotechnology Companies
  • Contract Manufacturing Organization
  • Pharma Marketing Companies
  • BioPharma Technology and Instruments Provider Companies
  • Pharmaceutical Industry Equipment and Services Suppliers
  • Contract Research Organization
  • Analytical Labs
  • Consulting Companies
  • Regional Government Organization
  • API Industries

Participants from Academia/Universities/Hospitals:
World Bio Pharma 2019 Congress welcomes Directors, Deans, Lab Heads, Scientists, Clinicians, Doctors, and Students with an interest towards drug discovery and development, drug delivery, analytical and bioanalytical techniques, biopharmaceuticals manufacturing, clinical trials, intellectual property and regulatory affairs, but are not limited to:

  • Drug Discovery & Development
  • Drug Delivery
  • Biopharma Manufacturing
  • Biosimilars & Biologics
  • Analytical and Bioanalytical Techniques
  • Bioavailability & Bioequivalence - BABE
  • Clinical Trials
  • Personalized Medicine
  • Intellectual Property
  • Regulatory Affairs
  • Vaccines
  • Advances in Antibiotics Discovery
  • Pharmacovigilance
  • Biopharmaceutics Applications
  • Clinical Pharmacology
  • Pharmaceutical Toxicology
  • Pharmaceutical Packaging and Marketing

Global biopharmaceuticals market was valued at $186,470 million in 2017 and is estimated to reach $390,210 million by 2023, registering a CAGR of 13.8% from 2017 to 2023. The global biopharmaceuticals market is driven by numerous factors such as the increase in the aged population, the prevalence of diseases such as diabetes, obesity, and cancer, and increase in adoption of biopharmaceuticals over the year globally. Moreover, the rise in strategic collaborations among biopharmaceuticals corporations is additionally anticipated to supplement the expansion of the biopharmaceuticals trade.

The emerging economies, such as China, Singapore and India, are anticipated to provide profitable growth opportunities to the key players involved in the business of the biopharmaceuticals market. However, the costs associated with drug development are high and their failure threats are factors anticipated to restrain the growth of the global biopharmaceuticals market. 

The top pharmaceutical companies in terms of revenue are

  • Johnson & Johnson
  • Roche
  • Pfizer
  • Novartis
  • Bayer
  • Merck & Co.
  • Glaxo Smith Kline
  • Sanofi
  • AbbVie
  • Abbott Laboratories
  • Eli Lilly & Co
  • Amgen
  • Bristol-Myers Squibb
  • Gilead Sciences
  • AstraZeneca
  • Teva Pharmaceutical Industries
  • Boehringer Ingelheim
  • Merck Group
  • Novo Nordisk
  • Allerganplc
  • Takeda Pharmaceutical
  • Shire
  • Celgene
  • Biogen

Join Our Newsletter